BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22832384)

  • 1. Genetic variants at 5p12 and risk of breast cancer in Han Chinese.
    Liu X; Qin Z; Shen H; Xue J; Jiang Y; Hu Z; Shen H; Wang S
    J Hum Genet; 2012 Oct; 57(10):638-41. PubMed ID: 22832384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study.
    Ruiz-Narvaez EA; Rosenberg L; Rotimi CN; Cupples LA; Boggs DA; Adeyemo A; Cozier YC; Adams-Campbell LL; Palmer JR
    Breast Cancer Res Treat; 2010 Sep; 123(2):525-30. PubMed ID: 20140701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study confirms two susceptibility loci for breast cancer in Chinese Han women.
    Xu M; Xu Y; Chen M; Li Y; Li W; Zhu J; Zhang M; Chen Z; Zhang X; Liu J; Zhang B
    Breast Cancer Res Treat; 2016 Oct; 159(3):433-42. PubMed ID: 27572337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.
    Wang X; Zhang L; Chen Z; Ma Y; Zhao Y; Rewuti A; Zhang F; Fu D; Han Y
    PLoS One; 2013; 8(9):e73611. PubMed ID: 24039999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
    Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
    Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs.
    Guan YP; Yang XX; Yao GY; Qiu F; Chen J; Chen LJ; Ye CS; Li M
    Asian Pac J Cancer Prev; 2014; 15(1):85-91. PubMed ID: 24528085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants at 14q24.1 and breast cancer susceptibility: a fine-mapping study in Chinese women.
    Ma H; Li H; Jin G; Dai J; Dong J; Qin Z; Chen J; Wang S; Wang X; Hu Z; Shen H
    DNA Cell Biol; 2012 Jun; 31(6):1114-20. PubMed ID: 22313133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population.
    Han J; Jiang T; Bai H; Gu H; Dong J; Ma H; Hu Z; Shen H
    Breast Cancer Res Treat; 2011 Oct; 129(3):901-7. PubMed ID: 21528353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer.
    Wang L; Jiang Y; Zhang Y; Wang Y; Huang S; Wang Z; Tian B; Yang Y; Jiang W; Pang D
    PLoS One; 2012; 7(3):e34400. PubMed ID: 22461912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.
    Zheng Y; Ogundiran TO; Falusi AG; Nathanson KL; John EM; Hennis AJ; Ambs S; Domchek SM; Rebbeck TR; Simon MS; Nemesure B; Wu SY; Leske MC; Odetunde A; Niu Q; Zhang J; Afolabi C; Gamazon ER; Cox NJ; Olopade CO; Olopade OI; Huo D
    Carcinogenesis; 2013 Jul; 34(7):1520-8. PubMed ID: 23475944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CD40 gene polymorphisms with sporadic breast cancer in Chinese Han women of Northeast China.
    Shuang C; Dalin L; Weiguang Y; Zhenkun F; Fengyan X; Da P; Li D
    PLoS One; 2011; 6(8):e23762. PubMed ID: 21912605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.
    Han JY; Wang H; Xie YT; Li Y; Zheng LY; Ruan Y; Song AP; Tian XX; Fang WG
    PLoS One; 2012; 7(11):e49296. PubMed ID: 23185313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.
    Yu Y; Chen Z; Wang H; Zhang Y
    PLoS One; 2013; 8(8):e72154. PubMed ID: 23977236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the performance of HapMap SNP data in a Shanghai Chinese population: analyses of allele frequency, linkage disequilibrium pattern and tagging SNPs transferability on chromosome 1q21-q25.
    Hu C; Jia W; Zhang W; Wang C; Zhang R; Wang J; Ma X; ; Xiang K
    BMC Genet; 2008 Feb; 9():19. PubMed ID: 18302794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
    Benusiglio PR; Lesueur F; Luccarini C; McIntosh J; Luben RN; Smith P; Dunning A; Easton DF; Ponder BA; Pharoah PD
    BMC Cancer; 2005 Jul; 5():81. PubMed ID: 16029503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between genetic variants of EGF-containing fibulin-like extracellular matrix protein1 gene and sporadic breast cancer in a Chinese Han population.
    Li X; Quan Y; Tang C; Chen Y
    Eur J Gynaecol Oncol; 2016; 37(1):80-5. PubMed ID: 27048115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms and haplotypes in the insulin-like growth factor 1 receptor (IGF1R) gene with the risk of breast cancer in Korean women.
    Kang HS; Ahn SH; Mishra SK; Hong KM; Lee ES; Shin KH; Ro J; Lee KS; Kim MK
    PLoS One; 2014; 9(1):e84532. PubMed ID: 24392142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
    Milne RL; Goode EL; García-Closas M; Couch FJ; Severi G; Hein R; Fredericksen Z; Malats N; Zamora MP; Arias Pérez JI; Benítez J; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Cox A; Brock IW; Elliot G; Cross SS; Seal S; Turnbull C; Renwick A; Rahman N; Shen CY; Yu JC; Huang CS; Hou MF; Nordestgaard BG; Bojesen SE; Lanng C; Grenaker Alnæs G; Kristensen V; Børrensen-Dale AL; Hopper JL; Dite GS; Apicella C; Southey MC; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Chang-Claude J; Wang-Gohrke S; Radice P; Peterlongo P; Manoukian S; Barile M; Giles GG; Baglietto L; John EM; Miron A; Chanock SJ; Lissowska J; Sherman ME; Figueroa JD; Bogdanova NV; Antonenkova NN; Zalutsky IV; Rogov YI; Fasching PA; Bayer CM; Ekici AB; Beckmann MW; Brenner H; Müller H; Arndt V; Stegmaier C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Meindl A; Heil J; Bartram CR; Schmutzler RK; Thomas GD; Hoover RN; Fletcher O; Gibson LJ; dos Santos Silva I; Peto J; Nickels S; Flesch-Janys D; Anton-Culver H; Ziogas A; Sawyer E; Tomlinson I; Kerin M; Miller N; Schmidt MK; Broeks A; Van 't Veer LJ; Tollenaar RA; Pharoah PD; Dunning AM; Pooley KA; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Jakubowska A; Lubinski J; Jaworska K; Durda K; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Kraft P; Lindstrom S; Chen X; Beesley J; Hamann U; Harth V; Justenhoven C; ; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning M; Hollestelle A; Oldenburg RA; Tilanus-Linthorst M; Khusnutdinova E; Bermisheva M; Prokofieva D; Farahtdinova A; Olson JE; Wang X; Humphreys MK; Wang Q; Chenevix-Trench G; ; ; Easton DF
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2222-31. PubMed ID: 21795498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
    Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
    PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men.
    Orr N; Cooke R; Jones M; Fletcher O; Dudbridge F; Chilcott-Burns S; Tomczyk K; Broderick P; Houlston R; Ashworth A; Swerdlow A
    PLoS Genet; 2011 Sep; 7(9):e1002290. PubMed ID: 21949660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.